The role of neutrophils in SAH

中性粒细胞在 SAH 中的作用

基本信息

  • 批准号:
    7201784
  • 负责人:
  • 金额:
    $ 16.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-02-02 至 2011-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Subarachnoid hemorrhage is the third leading cause of stroke in the United States but accounts for fifty percent of the mortality and morbidity in cerebral vascular events. The syndrome of delayed cerebral ischemia (vasospasm) is a common, dangerous and poorly understood complication of subarachnoid hemorrhage. Neutrophil infiltration is the predominant early inflammatory response in subarachnoid hemorrhage; however, the role of neutrophils and their products in mediating vasospasm has not been elucidated. Neutrophils make reactive oxidant species (ROS). ROS are implicated in the pathogenesis of vasospasm and are believed to contribute to oxidative injury and nitric oxide (NO) depletion. These are believed to contribute to the blood vessel dysfunction in vasospasm. We propose to test the hypothesis that neutrophil accumulation in the subarachnoid space and selective increase in neutrophil-derived molecular markers of oxidative pathways will correlate with the occurrence of vasospasm after subarachnoid hemorrhage. We plan to investigate this by developing two Specific Aims: 1) We will establish the relationship between neutrophil enrichment in the subarachnoid space, stable molecular markers of distinct oxidative pathways and vasospasm; and 2) we will determine the implications of neutrophil depletion, activation, the inactivation of two neutrophil enzymes, NADPH oxidase and MPO, and the inactivation of the chemokines CXCR2 on the development of vasospasm in a murine model. There is no effective treatment of vasospasm. This proposal will lead to a better understanding of the pathways by which neutrophil infiltration and action may lead to vasospasm. This is relevant because neutrophils and neutrophil chemokines are potential targets for pharmacologic therapy to prevent or treat vasospasm. This proposal and the educational components included form the basis for Dr. Provencio to develop into an independent physician-scientist.
描述(由申请人提供):蛛网膜下腔出血是美国中风的第三大原因,但占脑血管事件死亡率和发病率的50%。迟发性脑缺血(血管痉挛)综合征是蛛网膜下腔出血的一种常见、危险且鲜为人知的并发症。中性粒细胞浸润是蛛网膜下腔出血的主要早期炎症反应;然而,中性粒细胞及其产物在介导血管痉挛中的作用尚未阐明。中性粒细胞产生活性氧(ROS)。ROS参与血管痉挛的发病机制,并被认为有助于氧化损伤和一氧化氮(NO)的消耗。这些被认为是导致血管痉挛时血管功能障碍的原因。我们提出验证一种假设,即中性粒细胞在蛛网膜下腔的积聚和中性粒细胞衍生的氧化途径分子标志物的选择性增加与蛛网膜下腔出血后血管痉挛的发生有关。我们计划通过以下两个具体目标来对此进行研究:1)我们将建立蛛网膜下腔中性粒细胞富集、不同氧化途径的稳定分子标记和血管痉挛之间的关系;2)我们将在小鼠模型中确定中性粒细胞耗竭、激活、两种中性粒细胞酶(NADPH氧化酶和MPO)失活以及趋化因子CXCR2失活对血管痉挛发展的影响。血管痉挛没有有效的治疗方法。这一建议将有助于更好地理解中性粒细胞浸润和作用可能导致血管痉挛的途径。这是相关的,因为中性粒细胞和中性粒细胞趋化因子是预防或治疗血管痉挛的药物治疗的潜在靶点。这一建议和教育组成部分构成了普罗文西奥博士发展成为一名独立的医生科学家的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jose Javier Provencio其他文献

Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: The Role of the Complement and Innate Immune System
  • DOI:
    10.1007/s12975-024-01290-5
  • 发表时间:
    2024-08-21
  • 期刊:
  • 影响因子:
    4.300
  • 作者:
    Jose Javier Provencio;Sonya Inkelas;Mervyn D. I. Vergouwen
  • 通讯作者:
    Mervyn D. I. Vergouwen
ICP Monitoring for Bacterial Meningitis: Is This Just One of the Blind Spots in Neurocritical Care?
  • DOI:
    10.1007/s12028-024-01940-4
  • 发表时间:
    2024-02-17
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Jose Javier Provencio
  • 通讯作者:
    Jose Javier Provencio
Small Molecule Myeloperoxidase (MPO) Inhibition Prevents Delayed Cerebral Injury (DCI) After Subarachnoid Hemorrhage (SAH) in a Murine Model
  • DOI:
    10.1007/s12028-024-02169-x
  • 发表时间:
    2024-12-10
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Safiye Limon;Aminata P. Coulibaly;Jose Javier Provencio
  • 通讯作者:
    Jose Javier Provencio
Correction to: Proceedings of the Second Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness
  • DOI:
    10.1007/s12028-022-01536-w
  • 发表时间:
    2022-06-17
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Shraddha Mainali;Venkatesh Aiyagari;Sheila Alexander;Yelena Bodien;Varina Boerwinkle;Melanie Boly;Emery Brown;Jeremy Brown;Jan Claassen;Brian L. Edlow;Ericka L. Fink;Joseph J. Fins;Brandon Foreman;Jennifer Frontera;Romergryko G. Geocadin;Joseph Giacino;Emily J. Gilmore;Olivia Gosseries;Flora Hammond;Raimund Helbok;J. Claude Hemphill;Karen Hirsch;Keri Kim;Steven Laureys;Ariane Lewis;Geoffrey Ling;Sarah L. Livesay;Victoria McCredie;Molly McNett;David Menon;Erika Molteni;DaiWai Olson;Kristine O’Phelan;Soojin Park;Len Polizzotto;Jose Javier Provencio;Louis Puybasset;Chethan P. Venkatasubba Rao;Courtney Robertson;Benjamin Rohaut;Michael Rubin;Tarek Sharshar;Lori Shutter;Gisele Sampaio Silva;Wade Smith;Robert D. Stevens;Aurore Thibaut;Paul Vespa;Amy K. Wagner;Wendy C. Ziai;Elizabeth Zink;Jose I. Suarez
  • 通讯作者:
    Jose I. Suarez

Jose Javier Provencio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jose Javier Provencio', 18)}}的其他基金

Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定SAH后迟发性脑血管痉挛的治疗目标
  • 批准号:
    9165688
  • 财政年份:
    2015
  • 资助金额:
    $ 16.97万
  • 项目类别:
Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定 SAH 后迟发性脑血管痉挛的治疗目标
  • 批准号:
    8485699
  • 财政年份:
    2012
  • 资助金额:
    $ 16.97万
  • 项目类别:
Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定SAH后迟发性脑血管痉挛的治疗目标
  • 批准号:
    8703818
  • 财政年份:
    2012
  • 资助金额:
    $ 16.97万
  • 项目类别:
Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定SAH后迟发性脑血管痉挛的治疗目标
  • 批准号:
    8874313
  • 财政年份:
    2012
  • 资助金额:
    $ 16.97万
  • 项目类别:
Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定 SAH 后迟发性脑血管痉挛的治疗目标
  • 批准号:
    8297484
  • 财政年份:
    2012
  • 资助金额:
    $ 16.97万
  • 项目类别:
The role of neutrophils in SAH
中性粒细胞在 SAH 中的作用
  • 批准号:
    7535499
  • 财政年份:
    2007
  • 资助金额:
    $ 16.97万
  • 项目类别:
The role of neutrophils in SAH
中性粒细胞在 SAH 中的作用
  • 批准号:
    7993523
  • 财政年份:
    2007
  • 资助金额:
    $ 16.97万
  • 项目类别:
The role of neutrophils in SAH
中性粒细胞在 SAH 中的作用
  • 批准号:
    7348426
  • 财政年份:
    2007
  • 资助金额:
    $ 16.97万
  • 项目类别:
The role of neutrophils in SAH
中性粒细胞在 SAH 中的作用
  • 批准号:
    7739492
  • 财政年份:
    2007
  • 资助金额:
    $ 16.97万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.97万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了